A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic TransplantationKeith W. Pratz, Mark J. Levis, Ivana Gojo et al.|Transplantation and Cellular Therapy|2019Cited by 43
Prospective Study of Peri-Transplant Use of Sorafenib As Remission Maintenance for FLT3-ITD Patients Undergoing Allogeneic TransplantationKeith W. Pratz, Mark J. Levis, Ivana Gojo et al.|Blood|2015Cited by 28